K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 329 INR 9.38%
Market Cap: 5.3B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Intrinsic Value

The intrinsic value of one KILITCH stock under the Base Case scenario is 286.7 INR. Compared to the current market price of 329 INR, Kilitch Drugs (India) Ltd is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KILITCH Intrinsic Value
286.7 INR
Overvaluation 13%
Intrinsic Value
Price
K
Worst Case
Base Case
Best Case

Valuation Backtest
Kilitch Drugs (India) Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KILITCH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KILITCH?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Kilitch Drugs (India) Ltd

Provide an overview of the primary business activities
of Kilitch Drugs (India) Ltd.

What unique competitive advantages
does Kilitch Drugs (India) Ltd hold over its rivals?

What risks and challenges
does Kilitch Drugs (India) Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kilitch Drugs (India) Ltd.

Provide P/S
for Kilitch Drugs (India) Ltd.

Provide P/E
for Kilitch Drugs (India) Ltd.

Provide P/OCF
for Kilitch Drugs (India) Ltd.

Provide P/FCFE
for Kilitch Drugs (India) Ltd.

Provide P/B
for Kilitch Drugs (India) Ltd.

Provide EV/S
for Kilitch Drugs (India) Ltd.

Provide EV/GP
for Kilitch Drugs (India) Ltd.

Provide EV/EBITDA
for Kilitch Drugs (India) Ltd.

Provide EV/EBIT
for Kilitch Drugs (India) Ltd.

Provide EV/OCF
for Kilitch Drugs (India) Ltd.

Provide EV/FCFF
for Kilitch Drugs (India) Ltd.

Provide EV/IC
for Kilitch Drugs (India) Ltd.

Show me price targets
for Kilitch Drugs (India) Ltd made by professional analysts.

What are the Revenue projections
for Kilitch Drugs (India) Ltd?

How accurate were the past Revenue estimates
for Kilitch Drugs (India) Ltd?

What are the Net Income projections
for Kilitch Drugs (India) Ltd?

How accurate were the past Net Income estimates
for Kilitch Drugs (India) Ltd?

What are the EPS projections
for Kilitch Drugs (India) Ltd?

How accurate were the past EPS estimates
for Kilitch Drugs (India) Ltd?

What are the EBIT projections
for Kilitch Drugs (India) Ltd?

How accurate were the past EBIT estimates
for Kilitch Drugs (India) Ltd?

Compare the revenue forecasts
for Kilitch Drugs (India) Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kilitch Drugs (India) Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kilitch Drugs (India) Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kilitch Drugs (India) Ltd compared to its peers.

Compare the P/E ratios
of Kilitch Drugs (India) Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Kilitch Drugs (India) Ltd with its peers.

Analyze the financial leverage
of Kilitch Drugs (India) Ltd compared to its main competitors.

Show all profitability ratios
for Kilitch Drugs (India) Ltd.

Provide ROE
for Kilitch Drugs (India) Ltd.

Provide ROA
for Kilitch Drugs (India) Ltd.

Provide ROIC
for Kilitch Drugs (India) Ltd.

Provide ROCE
for Kilitch Drugs (India) Ltd.

Provide Gross Margin
for Kilitch Drugs (India) Ltd.

Provide Operating Margin
for Kilitch Drugs (India) Ltd.

Provide Net Margin
for Kilitch Drugs (India) Ltd.

Provide FCF Margin
for Kilitch Drugs (India) Ltd.

Show all solvency ratios
for Kilitch Drugs (India) Ltd.

Provide D/E Ratio
for Kilitch Drugs (India) Ltd.

Provide D/A Ratio
for Kilitch Drugs (India) Ltd.

Provide Interest Coverage Ratio
for Kilitch Drugs (India) Ltd.

Provide Altman Z-Score Ratio
for Kilitch Drugs (India) Ltd.

Provide Quick Ratio
for Kilitch Drugs (India) Ltd.

Provide Current Ratio
for Kilitch Drugs (India) Ltd.

Provide Cash Ratio
for Kilitch Drugs (India) Ltd.

What is the historical Revenue growth
over the last 5 years for Kilitch Drugs (India) Ltd?

What is the historical Net Income growth
over the last 5 years for Kilitch Drugs (India) Ltd?

What is the current Free Cash Flow
of Kilitch Drugs (India) Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kilitch Drugs (India) Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kilitch Drugs (India) Ltd

Current Assets 1.5B
Cash & Short-Term Investments 691m
Receivables 632.2m
Other Current Assets 136.6m
Non-Current Assets 940.7m
Long-Term Investments 228.5m
PP&E 481.2m
Intangibles 198.2m
Other Non-Current Assets 32.8m
Current Liabilities 642.2m
Accounts Payable 255.9m
Short-Term Debt 316.5m
Other Current Liabilities 69.8m
Non-Current Liabilities -4.5m
Other Non-Current Liabilities -4.5m
Efficiency

Earnings Waterfall
Kilitch Drugs (India) Ltd

Revenue
1.5B INR
Cost of Revenue
-954.9m INR
Gross Profit
557.8m INR
Operating Expenses
-395.6m INR
Operating Income
162.2m INR
Other Expenses
-36.4m INR
Net Income
125.8m INR

Free Cash Flow Analysis
Kilitch Drugs (India) Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KILITCH Profitability Score
Profitability Due Diligence

Kilitch Drugs (India) Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing
ROE is Increasing
52/100
Profitability
Score

Kilitch Drugs (India) Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

KILITCH Solvency Score
Solvency Due Diligence

Kilitch Drugs (India) Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Negative Net Debt
78/100
Solvency
Score

Kilitch Drugs (India) Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KILITCH Price Targets Summary
Kilitch Drugs (India) Ltd

Wall Street analysts forecast KILITCH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KILITCH is 475.32 INR with a low forecast of 470.66 INR and a high forecast of 489.3 INR.

Lowest
Price Target
470.66 INR
43% Upside
Average
Price Target
475.32 INR
44% Upside
Highest
Price Target
489.3 INR
49% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KILITCH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for KILITCH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Kilitch Drugs (India) Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

5.3B INR

Dividend Yield

0%

Description

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

Contact

MAHARASHTRA
Mumbai
37, Ujagar Industrial Estate, Waman Tukaram Patil Marg, Deonar
+912261214100
www.kilitch.com

IPO

1994-02-14

Employees

123

Officers

Executive Chairman & MD
Mr. Mukund Prataprai Mehta B.Com., LL.B.
Managing Director
Ms. Mira Bhavin Mehta
Whole-time Director
Mr. Bhavin Mukund Mehta B.Pharm.
Chief Financial Officer
Mr. Sunil Sureshji Jain
VP-Marketing & Operation
Tajouddin Ansari
General Manager - Administration
Rajesh Khatri
Show More
Company Secretary & Compliance Officer
Ms. Pushpa Nyoupane
Show Less

See Also

Discover More
What is the Intrinsic Value of one KILITCH stock?

The intrinsic value of one KILITCH stock under the Base Case scenario is 286.7 INR.

Is KILITCH stock undervalued or overvalued?

Compared to the current market price of 329 INR, Kilitch Drugs (India) Ltd is Overvalued by 13%.

Back to Top